Skip to main content
. 2021 Oct 14;107(6):1397–1409. doi: 10.3324/haematol.2021.279229

Table 2.

Overall extent of exposure in patients with and without renal impairment in the isatuximab (Isa) carfilzomib (K) dexamethasone (d) (Isa-Kd) and Kd arms – safety population

graphic file with name 1071397.tab2.jpg